Vanessa McDonald
@nessmcd
Followers
1K
Following
13K
Media
193
Statuses
2K
Prof Nursing. CoDirector @traitscre, @SevereAsthmaCRE. Director HMRI Asthma & Breathing Uni Newcastle. Views my own. 🫁 #lunghealth
Newcastle, Australia
Joined June 2010
This week is the official commencement of our new Centre of Excellence in Treatable Traits! To kick off we have launched our twitter acc. & logo. We are really excited to generate #treatabletraits knowledge, collaborate, translate and train the next generation. Follow us 4 more!
1/5 We are excited to launch the Centre of Excellence in #TreatableTraits! It is an international collaboration aiming to revolutionise chronic #airway disease management. Our team include:
7
5
61
Bronchoscopy & Pleural Workshop underway for @tsanz_thoracic 2024 Hub. Thx to facilitators: @vin_george2 @JeevanGERRARD10 Dan Steinfort +Tracy Leong +Lou Irving and the Northern Hosp pleural team @NCARD_research @uwanews @TOGAANZ
0
3
22
Bushfire smoke can harm your health, especially if you live with a lung disease! Our friends over at Centre for Safe Air have developed an a Bushfire Smoke fact sheet to help you get prepared: https://t.co/FzXnFZTZQ9
0
5
7
Prof Anne Holland provides an overview of the European Respiratory Society Clinical Practice Guideline on Symptom Management -including breathlessness and fatigue-for Adults with Serious Respiratory Illness
0
5
14
Fantastic to be at the opening of the @tsanz_thoracic Education Hub with minster @MaryAnneThomas and education hub chair @nessmcd. Looking forward to three days of learning and collaborations! #lung #lunghealth #lunglearning
0
2
8
#WorldLungDay advocates for the right of all people to Clean Air & Healthy Lungs. We support @FIRS_LungsFirst message to encourage communities & governments to invest in #lunghealth & combat #airpollution. For more head to our clinical resources page https://t.co/GPK8YSRDx6
0
5
11
A treatable traits approach to physiotherapy and nursing care in Bronchiectasis. Congrats Kirsty Watson on your 2nd PhD study @ZoeMcKeough, Tiffany Dwyer, @AnnemarieLLee1
1
8
42
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype | New England Journal of Medicine https://t.co/Sfm3yEHdlT
@ers2024
nejm.org
Depemokimab is an ultra-long-acting biologic therapy with enhanced binding affinity for interleukin-5 that may enable effective 6-month dosing intervals. In these phase 3A, randomized, placebo-cont...
0
5
18
OMG! 4 years of my life will be presented at #ERSCongress2024. For those not in the room, I will live tweet the results of the ABRA trial (Acute BenRAlizumab for exacerbations). @MonaBafadhel is setting off 🧵
8
24
98
It was great to sit at the desk with @briandkent and @asthmalondon. Something a little different for us at #ERSCongress2024 Stay tuned on the @EuroRespSoc channel for the severe asthma #cme activity!
Great to finally sit behind the @EuroRespSoc studio desk with @asthmalondon & @nessmcd. Listen to our ramblings on severe asthma on the ERS Respiratory Channel soon! #ERSCongress24
3
1
21
🌏Respirology New review series issue: Treatable traits—personalised medicine for life in airway disease https://t.co/4dhCxnsiai
@nessmcd @PeterThorSoc @traitsCRE @CDharmage @HLewthwaite
0
4
6
Want to come along to the #TSANZ education hub and have a chance for free registration to next year��s ASM? Book now! @tsanz_thoracic
0
4
7
Make sure you register this week to take advantage of the early bird 🐦 rates! ♥️🫁🫁🫁🫁🫁🫁🫁🫁🫁🫁
Join us for the TSANZ Education Hub in Melbourne from the 10 to 12 October, 2024. The Education Hub consists of a carefully curated program that aims to educate and foster collaboration and dialogue that can lead to tangible improvements in lung health #tsanz #tsanzeducation
0
4
3
Azithromycin effects on remission! Great paper led by Dennis Thomas for the @traitsCRE
Hot off the press! Article Alert: Effect of Azithromycin on Asthma Remission in Adults With Persistent Uncontrolled Asthma: A Secondary Analysis of a Randomized, Double-Anonymized, Placebo-Controlled Trial. #asthma #remission
https://t.co/pwM5zEHg2L
0
1
4
Pre-COPD is here to stay until we find solutions-let’s work together to solve this novel paradigm
Article Alert: Treatable traits in pre‐COPD: Time to extend the treatable traits paradigm beyond established disease - Dharmage - 2024 - Respirology - Wiley Online Library https://t.co/OItkxMtrqa
0
9
15
Join us for the TSANZ Education Hub in Melbourne from the 10 to 12 October, 2024. The Education Hub is a conference that consists of a carefully curated program that aims to educate and foster collaboration and dialogue that can lead to tangible improvements in lung health.
0
2
2
Join us for the 2024 @tsanz_thoracic Education Hub. It promises to be a great meeting with something for everyone! Early 🦜ends 26/7! https://t.co/SPSg0JnvdG
0
4
5
In Current Issue! Living With #Asthma and #Vocal Cord #Dysfunction/Inducible #Laryngeal Obstruction: “I Just Can’t Get Air In”
0
3
9
Article Alert: Treatable traits in pre‐COPD: Time to extend the treatable traits paradigm beyond established disease - Dharmage - 2024 - Respirology - Wiley Online Library https://t.co/OItkxMtrqa
onlinelibrary.wiley.com
To date, the treatable traits (TTs) approach has been applied in the context of managing diagnosed diseases. TTs are clinical characteristics and risk factors that can be identified clinically...
0
11
17
Mundipharma's new agreement with #BigTobacco giant PMI's inhaler device manufacturer @VecturaGroup crosses the red line set by respiratory organisations in 2021. @tsanz_thoracic has adopted a principled but practical approach to the new agreement. Read: https://t.co/1feF2ThKmb
0
6
6
1st paper from understanding breathlessness in asthma (UBA) study looking at burden & psychophysiological correlates>53% (optimally treated) severe asthma have limiting breathlessness assoc w ACQ, BMI, 6MWD, Nijmegen (treatable traits) https://t.co/BBBPsu46Tq
@traitsCRE @nessmcd
1
9
34